BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 11, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Aqueous sodium ion batteries developed for medical devices

Aug. 14, 2017
By John Fox
New flexible belt- and fiber-shaped electrodes in sodium ion-containing batteries (SIBs) with aqueous electrolytes, which have promising potential applications as safe power sources for wearable or implantable medical devices, have been developed by Chinese researchers.
Read More

New target identified for hard to treat breast cancer types

Aug. 9, 2017
By John Fox
An Australian study reported in the Aug. 2, 2017, edition of Science Translational Medicine has identified a promising new potential target in preclinical models of triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2 (HER2)-amplified breast cancer (BC).
Read More

New target identified for hard to treat breast cancer types

Aug. 4, 2017
By John Fox
An Australian study reported in the Aug. 2, 2017, edition of Science Translational Medicine has identified a promising new potential target in preclinical models of triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2 (HER2)-amplified breast cancer (BC).
Read More

Presynaptic dysfunction mechanism identified in Alzheimer's disease

Aug. 2, 2017
By John Fox
HONG KONG – A new Korean study has identified a novel cellular mechanism underlying presynaptic dysfunction in Alzheimer's disease (AD), which could represent an urgently needed new drug target for early stage AD.
Read More

Study finds potential new treatment for Zika virus

Aug. 2, 2017
By John Fox
A potent new anti-Zika virus peptide that appears to be safe and reduces viral levels in pregnant mice and their fetuses, has been identified in a Chinese study published in the July 25, 2017, edition of Nature Communications.
Read More

Study finds potential new treatment for Zika virus

Aug. 1, 2017
By John Fox

Study finds potential new treatment for Zika virus

July 31, 2017
By John Fox
A potent new anti-Zika virus peptide that appears to be safe and reduces viral levels in pregnant mice and their fetuses, has been identified in a Chinese study published in the July 25, 2017, edition of Nature Communications.
Read More

Genome therapy promises new blood disease treatments

July 27, 2017
By John Fox

Presynaptic dysfunction mechanism identified in Alzheimer's disease

July 27, 2017
By John Fox
HONG KONG – A new Korean study has identified a novel cellular mechanism underlying presynaptic dysfunction in Alzheimer's disease (AD), which could represent an urgently needed new drug target for early stage AD.
Read More

Genome therapy promises new blood disease treatments

July 26, 2017
By John Fox
HONG KONG – In a study led by Australian scientists at University of New South Wales (UNSW), introducing a beneficial natural mutation into blood cells using gene-editing was shown to stimulate production of fetal hemoglobin (Hb), a finding that could lead to a cure for blood diseases.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Art concept for inflammation in the intestines

    Kymera’s IRF5 degrader shows potential in IBD treatment

    BioWorld Science
    At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing